SequelSEC

Autonomix Medical, Inc. AMIX

Surgical & Medical Instruments & Apparatus · CIK 0001617867 · Fiscal year ends 0331

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2026-03-31
Operating income
-$17.03M
Fiscal year ended 2026-03-31
Free cash flow
-$12.29M
Fiscal year ended 2026-03-31

Autonomix Medical, Inc. (AMIX) reported revenue of $0 and net income of -$16.72M for the fiscal year ended 2026-03-31. This page shows 4 annual periods of income statement, balance sheet and cash flow figures normalized from Autonomix Medical, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Autonomix Medical, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-03-312024-03-312023-03-31
Revenue$0$0$0$0
Cost of revenueUnavailableUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailableUnavailableUnavailable
Operating income-$17.03M-$11.59M-$12.03M-$1.99M
Net income-$16.72M-$11.41M-$15.43M-$1.99M
Research & development$7.14M$4.72M$2.22M$745.00K
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailable
Pretax income-$16.72M-$11.41M-$15.43M-$1.99M
Income tax expense$0$0$0$0
Diluted EPSUnavailableUnavailableUnavailableUnavailable
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailable
General & administrative$9.89M$6.86M$5.25M$1.24M
Selling & marketingUnavailableUnavailableUnavailableUnavailable

Balance

Autonomix Medical, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-03-312024-03-312023-03-31
Cash & equivalents$7.00M$9.14M$8.61M$865.00K
Total assets$7.60M$9.81M$9.41M$865.00K
Current assets$7.58M$9.61M$9.39M$865.00K
Total liabilities$1.70M$1.71M$1.78M$221.00K
Current liabilities$1.70M$1.71M$777.00K$221.00K
Total equity incl. NCI$5.90M$8.10M$7.63M$644.00K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailable$0
Accounts payable$700.00K$676.00K$492.00K$173.00K

Cash flow

Autonomix Medical, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-03-312024-03-312023-03-31
Operating cash flow-$12.28M-$8.26M-$6.60M-$1.85M
Capital expenditures$10.00K$14.00K$19.00K$0
Investing cash flow-$10.00K-$14.00K-$19.00K$0
Financing cash flow$10.16M$8.80M$14.41M$675.00K
Net change in cash-$2.13M$528.00K$7.74M-$1.18M
Stock-based compensation$529.00K$1.63M$618.00K$0
Common dividends paidUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailable
Depreciation & amortization$12.00K$183.00K$81.00K$0

Derived

Autonomix Medical, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-03-312025-03-312024-03-312023-03-31
Free cash flow-$12.29M-$8.27MUnavailable-$1.85M
Gross marginUnavailableUnavailableUnavailableUnavailable
Operating marginUnavailableUnavailableUnavailableUnavailable
FCF marginUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailable
Current ratio4.45x5.63x12.09x3.91x
Revenue YoY growthUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AMIX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-K · Filed 2026-05-27View SEC filing
10-Q · Filed 2026-02-11View SEC filing
10-Q · Filed 2025-11-12View SEC filing
10-Q · Filed 2025-08-13View SEC filing
10-K · Filed 2025-05-29View SEC filing

Companies in the same industry

ADGM AEMD ALUR ANGO ANIK AORT APYX ARAY ATEC ATRC AURX BAX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.